Figure 2From: Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study Percentage of subjects with anti-HBs concentration ≥10 mIU/mL at all long-term follow-up time points (Long-term ATP cohort for immunogenicity).Back to article page